Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS
- Author(s)
- Horton, M; Leung, B; Nelles, R; Rubic, M; McKinnely, C; Cibich, A; Dowling, MR; HUNT, S; Chee, LCY; Scott, AP; Ritchie, DS; Hiwase, D; Purtill, D; Bhattacharya, A; Kennedy, GA; Bajel, A;
- Journal Title
- Bone Marrow Transplantation
- Publication Type
- Apr 23
- Publisher
- Springer Nature
- Research Division(s)
- Immunology
- PubMed ID
- 42026192
- Publisher's Version
- https://doi.org/10.1038/s41409-026-02874-5
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-04-27 03:52:44
Last Modified: 2026-04-27 03:52:54